Real-time enrollment status for this drug resistant epilepsy clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 8:25 AM UTC
| NCT Number | NCT05019885 |
| Recruiting Status | Recruiting |
| Condition | Drug Resistant Epilepsy |
| Phase | PHASE2 |
| Target Enrollment | 8 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Madeline Fields |
| Last Updated on CT.gov | August 15, 2025 (Aug 15, 2025) |
As of August 31, 2026: Clinical trial NCT05019885 is currently recruiting participants. This phase2 study for drug resistant epilepsy is actively seeking new participants at 1 location across the United States. The study is sponsored by Madeline Fields. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05019885 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05019885 was last updated Aug 15, 2025 (August 15, 2025). HelloStudys verifies this status automatically.